Trial ID	IBS-SSS score		IBS-QoL score		IBS subtypes (FMT/placebo)	Follow-up time		Lost to follow-up
	FMT	placebo	FMT	placebo				FMT	placebo
NCT02299973	380(270-390)	370(310-440)	32.6(11-119)	29.1 (22-61)	IBS-D IBS-M	12 weeks 1 year		0/43	1/19
NCT02788071	341.68±95.02	345.04±79.56	42.07±14.75	40.11±15.42	IBS-C:7/10 IBS-D:7/8 IBS-M:11/8	1, 3, 6 months		1/26	0/26
NCT03822299	311.8±76.8 313.9±87.3	315.2±77.1	109.1±22.7 113.4±22.4	117.8±19.7	IBS-C:20/20/22 IBS-D:22/20/21 IBS-M:13/14/12	2 weeks 1, 3 months		1/110	0/55
NCT03561519	282.5±85.4	263.5 (93.2)	56.9±19.9	57.2±20.3	IBS-D:9/16 IBS-M:3/4 IBS-other:11/6	4, 8, 12, 26, 52 weeks		4/27	2/28
NCT02154867	260(226-313)	278(223-254)	57.7±19.1	49.2±20.6	IBS-D:31/13 IBS-M:24/15	3, 12 months		2/57	2/30
NCT02328547	282±65	309±64	53±18	52±18	IBS-D:25/23	12 weeks 24 weeks		3/25	0/23
NCT02092402	No reported	No reported	No reported	No reported	IBS-C:1/3 IBS-D:5/4 IBS-M:2/1	2, 4, 8 weeks 6 months		0/8	2/9
NCT02847481	347.5±59.0	282.3±70.7	42.7±19.2	47.6±13.4	IBS-D: 11/12	1, 10 weeks		3/11	1/12
ChiCTR1900024924	291.11±42.28	284.44±40.86	43.33±7.53	44.11±7.61	IBS-D: 9/9	1 week 1, 2, 3 months		0/9	0/9